Stent Evaluation with Optical Coherence Tomography

키워드

참고문헌 (61)

1. Serruys PW, "A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group", N Engl J Med, 331, pp.489~495 (1994)
2. Fischman DL, "A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators", N Engl J Med, 331, pp.496~501 (1994)
3. Forrester JS, "A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies", J Am Coll Cardiol, 17, pp.758~769 (1991)
4. Virmani R, "Pathology of in-stent restenosis", Curr Opin Lipidol, 10, pp.499~506 (1999)
5. Moses JW, "Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery", N Engl J Med, 349, pp.1315~1323 (2003)
6. Stone GW, "A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease", N Engl J Med, 350, pp.221~231 (2004)
7. Daemen J, "Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study", Lancet, 369, pp.667~678 (2007)
8. Wenaweser P, "Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study", J Am Coll Cardiol, 52, pp.1134~1140 (2008)
9. Suzuki Y, "In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation", JACC Cardiovasc Interv, 1, pp.168~173 (2008)
10. Kwon SW, "Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound", Am Heart J, 161, pp.367~372 (2011)
11. Takarada S, "Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion", Catheter Cardiovasc Interv, 75, pp.202~206 (2010)
12. Bezerra HG, "Optical coherence tomography versus intravascular ultrasound to evaluate coronary artery disease and percutaneous coronary intervention", JACC Cardiovasc Interv, 6, pp.228~236 (2013)
13. Nakano M, "Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging", JACC Cardiovasc Imaging, 5, pp.71~82 (2012)
14. Hong MK, "Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up", Circulation, 113, pp.414~419 (2006)
15. Tearney GJ, "Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation", J Am Coll Cardiol, 59, pp.1058~1072 (2012)
16. Kim WH, "Serial changes of minimal stent malapposition not detected by intravascular ultrasound: follow-up optical coherence tomography study", Clin Res Cardiol, 99, pp.639~644 (2010)
17. Kim JS, "Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation", Int J Cardiovasc Imaging, 28, pp.1281~1287 (2012)
18. Choi HH, "Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography", Int J Cardiovasc Imaging, 28, pp.491~497 (2012)
19. Gutiérrez-Chico JL, "Long-term tissue coverage of a biodegradable polylactide polymer-coated biolimus-eluting stent: comparative sequential assessment with optical coherence tomography until complete resorption of the polymer", Am Heart J, 162, pp.922~931 (2011)
20. Katoh H, "Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography", Circ J, 73, pp.1033~1037 (2009)
21. Gutiérrez-Chico JL, "Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography", Circ Cardiovasc Interv, 5, pp.20~29 (2012)
22. Kawamori H, "Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up", Eur Heart J Cardiovasc Imaging (2013)
23. Gutiérrez-Chico JL, "Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography", Circulation, 124, pp.612~623 (2011)
24. Kim BK, "Relationship between stent malapposition and incomplete neointimal coverage after drug-eluting stent implantation", J Interv Cardiol, 25, pp.270~277 (2012)
25. Kim BK, "Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation", Int J Cardiovasc Imaging, 28, pp.1887~1894 (2012)
26. Kim JS, "Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT", JACC Cardiovasc Imaging, 5, pp.1147~1155 (2012)
27. Takano M, "Late vascular responses from 2 to 4 years after implantation of sirolimus-eluting stents: serial observations by intracoronary optical coherence tomography", Circ Cardiovasc Interv, 3, pp.476~483 (2010)
28. Finn AV, "Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization", Circulation, 115, pp.2435~2441 (2007)
29. Matsumoto D, "Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography", Eur Heart J, 28, pp.961~967 (2007)
30. Kim JS, "Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation", Circ J, 74, pp.320~326 (2010)
31. Kim JS, "Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents", Heart, 95, pp.1907~1912 (2009)
32. Kim BK, "A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)", J Am Coll Cardiol, 60, pp.1340~1348 (2012)
33. Sarno G, "Lower risk of stent thrombosis and restenosis with unrestricted use of ‘new-generation’ drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)", Eur Heart J, 33, pp.606~613 (2012)
34. Barlis P, "An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study", Eur Heart J, 31, pp.165~176 (2010)
35. Stefanini GG, "Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial", Lancet, 378, pp.1940~1948 (2011)
36. Guagliumi G, "Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging", JACC Cardiovasc Interv, 5, pp.12~20 (2012)
37. Won H, "Optical coherence tomography derived cut-off value of uncovered stent struts to predict adverse clinical outcomes after drug-eluting stent implantation", Int J Cardiovasc Imaging (2013)
38. 김병극, "Comparison of Optical Coherence Tomographic Assessment between First- and Second-Generation Drug-Eluting Stents", Yonsei Medical Journal, 53(3), pp.524~529 (2012), 연세대학교의과대학[DOI]
39. Gonzalo N, "Optical coherence tomography patterns of stent restenosis", Am Heart J, 158, pp.284~293 (2009)
40. Lee SJ, "Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study", Clin Cardiol, 34, pp.633~639 (2011)
41. Nakazawa G, "The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents", J Am Coll Cardiol, 57, pp.1314~1322 (2011)
42. Prati F, "Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis", Eur Heart J, 31, pp.401~415 (2010)
43. Yonetsu T, "Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography", Am J Cardiol, 110, pp.933~939 (2012)
44. Yonetsu T, "Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry", Circ Cardiovasc Imaging, 5, pp.660~666 (2012)
45. Habara M, "Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study", Circ Cardiovasc Interv, 4, pp.232~238 (2011)
46. Habara M, "Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study", Eur Heart J Cardiovasc Imaging, 14, pp.276~284 (2013)
47. Kimura T, "Three-year follow-up after implantation of metallic coronary-artery stents", N Engl J Med, 334, pp.561~566 (1996)
48. Collet CA, "Assessing the temporal course of neointimal hyperplasia formation after different generations of drug-eluting stents", JACC Cardiovasc Interv, 4, pp.1067~1074 (2011)
49. Kang SJ, "Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation", Circulation, 123, pp.2954~2963 (2011)
50. Ko YG, "Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation", Int J Cardiovasc Imaging, 28, pp.715~723 (2012)
51. Nagai H, "Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis", Catheter Cardiovasc Interv, 75, pp.961~963 (2010)
52. Okamura T, "3-Dimensional optical coherence tomography assessment of jailed side branches by bioresorbable vascular scaffolds: a proposal for classification", JACC Cardiovasc Interv, 3, pp.836~844 (2010)
53. Ha J, "Assessing neointimal coverage after DES implantation by 3D OCT", JACC Cardiovasc Imaging, 5, pp.852~853 (2012)
54. Giattina SD, "Assessment of coronary plaque collagen with polarization sensitive optical coherence tomography (PS-OCT)", Int J Cardiol, 107, pp.400~409 (2006)
55. Tahara N, "Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis", J Nucl Med, 50, pp.331~334 (2009)
56. Kim JS, "Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial", JACC Cardiovasc Interv, 2, pp.1240~1247 (2009)
57. Kim S, "Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography", Am J Cardiol, 111, pp.1~5 (2013)
58. Gutiérrez-Chico JL, "Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial", Eur Heart J, 32, pp.2454~2463 (2011)
59. Inoue T, "Optical coherence evaluation of everolimus-eluting stents 8 months after implantation", Heart, 97, pp.1379~1384 (2011)
60. Takano M, "Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: comparison with paclitaxel-eluting stents", Int J Cardiol, 166, pp.181~186 (2013)
61. Kim TH, "Long-term (≥2 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results", Int J Cardiovasc Imaging, 27, pp.875~881 (2011)

관련 논문AI추천